|
Different between tumor and
tumor-adjacent
gastric tissue
| | | |
|
Pathways in cancer
|
hsa05200
|
0.0000014
|
DCC, WNT5A, FGF5, RET, FGF8, FLT3, PPARG, TGFB3, FGF12, MMP2, GLI3, TGFB2, WNT2, SMO, CSF3R, HHIP, CCNA1, FGF2, FGF3
|
|
Hedgehog signaling pathway
|
hsa04340
|
0.0015474
|
WNT2, WNT5A, SMO, HHIP, GLI3, BMP6
|
|
Cytokine-cytokine receptor interaction
|
hsa04060
|
0.0019703
|
LIF, FLT1, FLT3, FLT4, IFNG, TGFB3, CSF3R, NGFR, KDR, TNFSF8, EPO, TGFB2
|
|
Basal cell carcinoma
|
hsa05217
|
0.0096687
|
WNT2, WNT5A, SMO, HHIP, GLI3
|
|
Hematopoietic cell lineage
|
hsa04640
|
0.0098799
|
CD34, FLT3, CD2, CSF3R, MME, EPO
|
|
MAPK signaling pathway
|
hsa04010
|
0.0201135
|
FGF5, FGF8, RASGRF1, NTRK2, MOS, TGFB3, FGF12, FGF2, FGF3, TGFB2
|
|
Melanoma
|
hsa05218
|
0.0229304
|
FGF5, FGF8, FGF12, FGF2, FGF3
|
|
TGF-beta signaling pathway
|
hsa04350
|
0.0437881
|
IFNG, TGFB3, THBS2, BMP6, TGFB2
|
|
Regulation of actin cytoskeleton
|
hsa04810
|
0.0456631
|
FGF5, FGF8, TIAM1, INS, MOS, FGF12, FGF2, FGF3
|
|
Axon guidance
|
hsa04360
|
0.0471078
|
DCC, EPHA7, EPHA8, SEMA3C, FES, SLIT2
|
|
Different between tumor subtype H and L
| | | |
|
Pathways in cancer
|
hsa05200
|
0.0000012
|
DCC, WNT5A, FGF5, FGF8, RET, FLT3, MMP2, GLI3, TGFB2, WNT2, SMO, HHIP, CCNA1, FGF3
|
|
Hedgehog signaling pathway
|
hsa04340
|
0.0000843
|
WNT2, WNT5A, SMO, HHIP, GLI3, BMP6
|
|
Basal cell carcinoma
|
hsa05217
|
0.0010110
|
WNT2, WNT5A, SMO, HHIP, GLI3
|
|
Cytokine-cytokine receptor interaction
|
hsa04060
|
0.0194278
|
FLT1, FLT3, FLT4, NGFR, KDR, EPO, TGFB2
|
